| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.7M | -3.6% |
| Cost of Revenue | $30.1M | -23.6% |
| R&D Expense | $23.9M | -42.8% |
| SG&A Expense | $71.1M | -27.2% |
| Operating Income | -$75.5M | +31.6% |
| Interest Expense | $255K | — |
| Pre-tax Income | -$74.9M | +20.2% |
| Income Tax | $189K | +339.5% |
| Net Income | -$75.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $82.8M | +28.5% |
| Inventory | $15.3M | -43.4% |
| Current Assets | $104.9M | +6.6% |
| Total Assets | $146.4M | -1.0% |
| Current Liabilities | $22.7M | -24.1% |
| Long-term Debt | $74.2M | — |
| Total Liabilities | $100.4M | +205.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.5M | +42.9% |
| Capital Expenditures | $3.8M | -52.8% |
| Investing Cash Flow | -$3.8M | +52.8% |
| Financing Cash Flow | $75.7M | +5344.8% |
| Free Cash Flow | -$57.4M | +43.7% |
| +20.0% |
| EPS (Basic) | -$0.37 | +19.6% |
| EPS (Diluted) | -$0.37 | +19.6% |
| Stockholders' Equity |
| $46.0M |
| -60.0% |